RE: Covid Tests Will Stay in Short Supply, Roche CEO Predicts21 Nov 2020 15:50
We have to look beyond H1 2021 and determine where the normalised revenue streams will come from to deliver continuous growth, beyond a £750M + run rate.
It’s now about great customer service in meeting the demand within the contracts and not over promising and under performing. Let’s hope capacity = demand.
Great to see their category management strategy working on margin mix & general product management. Clear professional Supply chain function with competent Teams within. Bodes well for future growth & margin protection. Retail is detail.